Cytodyn Inc (CYDY)

[Northstar42]

Who will be the CYDY nominees for the BOD? Will it include Jordan Naydenov, Alan Timmins, Gordan Gardiner and/or Samir Patel? Have shareholders ever heard a public word from any of these current Directors? On what basis would you justify giving them your proxy vote?

I ask these questions because the alternative nominees, Bruce Patterson, Thomas Errico, Paul Rosenbaum, Peter Staats, and Melissa Yeager are being intensely vetted on social media, which is the right thing to do. Similarly, it is entirely appropriate and necessary for shareholders to assess the fiduciary credentials of those already holding BOD seats (assuming they are nominated). That is being done, some would say ad nauseam, with regard to Nader Pourhassan and Scott Kelly.

So what's my point? When push comes to shove, we will have a choice among individual candidates, not "company" vs "activist shareholders". IMO, the best interests of shareholders will be served by a diverse BOD with complimentary experience, knowledge, skills, and judgement perspectives. Most importantly, all candidates, including the existing Directors, should be held to the same standard of scrutiny. If you read the recent 14A Filing you will notice that there is discussion of what may occur post election, if some, but not all, of their nominees win.